Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeting the KRAS a4-a5 allosteric interface inhibits pancreatic cancer tumorigenesis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting the KRAS a4-a5 allosteric interface inhibits pancreatic cancer tumorigenesis.
Targeting the KRAS a4-a5 allosteric interface inhibits pancreatic cancer tumorigenesis. Small GTPases. 2022 Jan; 13(1):114-127.
View in:
PubMed
subject areas
Animals
Carcinogenesis
Carcinoma, Pancreatic Ductal
Humans
Mice
Pancreatic Neoplasms
Proto-Oncogene Proteins p21(ras)
authors with profiles
Dean M. Connor
Ann-Marie Broome
Michael C Ostrowski
Cynthia Timmers
Imran Khan
John P. O'Bryan
Mariyam Zuberi